Results 121 to 130 of about 12,163 (157)

Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice. [PDF]

Vaccines (Basel), 2019
Kilpeläinen A, Saubi N, Guitart N, Olvera A, Hanke T, Brander C, Joseph J.   +6 more
europepmc   +1 more source

Adjuvanted Recombinant BCG Vaccine increases protection against TB

, 2012
Nascimento, I., Rodrigues, D., Winter, Nathalie, Gicquel, B., Pizza, M., Rappuoli, R., Leite, L.   +6 more
openaire   +3 more sources

Enhanced immunogenicity of Staphylococcus aureus IsdE vaccine with SeNPs and BCG adjuvants in mice. [PDF]

AMB Express
Khosravani Pour F, Haghighat S, Yazdi MH, Hassanzadeh SM.   +3 more
europepmc   +1 more source

Long-Term Protective Immune Responses Induced by rBCG-RBD/rRBD Heterologous Prime/Boost Immunization Strategy: Fusion of RBD-Wuhan with LTB Adjuvant Induces Cross-Reactivity with SARS-CoV-2 Variant Omicron. [PDF]

Vaccines (Basel)
Gaboardi GC, Trentini MM, Kanno AI, Moraes L, Januzzi AD, Pereira LR, Dias GBM, Huergo LF, Oliveira SC, Bafica A, Leite LCC.   +10 more
europepmc   +1 more source

An Rv1471-expressing chimpanzee adenovirus vaccine confers protection against tuberculosis by inducing alveolar macrophage trained immunity and polyfunctional T-cell responses. [PDF]

Emerg Microbes Infect
Wang H, Zhang Y, Li J, Wu J, Huang S, Xie S, Huang X, Wang J, Fan XY, Hu Z.   +9 more
europepmc   +1 more source

rBCG-LTAK63 Outperforms BCG in Bladder Cancer Immunotherapy: Dendritic and T Cell Coordination Drives Superior Tumor Control in a Mouse Model. [PDF]

Int J Biol Sci
de Almeida MF, Rosa BG, Delechiave D, Annequin LF, Marques-Neto LM, Trentini MM, van Vliet JC, Gozzi ICC, Carvalho ACO, Rodriguez D, Pereira LR, Gaboardi GC, Ferreira LCS, Leite LCC, Moreno ACR.   +14 more
europepmc   +1 more source

Evaluation of TST/C-TST combination for latent tuberculosis infection screening: diagnostic performance and cost-effectiveness compared to TST/IGRAs. [PDF]

BMC Infect Dis
Zhang X, Mao L, Nie R, Guo D, Su Y, Wang R, Dong E, Nie Y, An H, Lv H, Liu F, Chen Z, Xu Y, Du J.   +13 more
europepmc   +1 more source

Analysis of the drug target of the anti-tuberculosis compound OCT313: phosphotransacetylase is a potential drug target for anti-mycobacterial agents. [PDF]

mSphere
Takii T, Hasegawa T, Itoh S, Maeda S, Wada T, Horita Y, Nishiyama A, Matsumoto S, Ohara N, Kimishima A, Asami Y, Hida S, Onozaki K.   +12 more
europepmc   +1 more source

Genetic and immunologic determinants of BCG disease: from mechanism to prevention. [PDF]

Ann Med
Chen F, Shen Y, Yan Q, Zheng D, Chen X, Fang L, Sun M, Zhang Y, Chu M, Yang E, Huang XF.   +10 more
europepmc   +1 more source